<PAGE>
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. )
Filed by the Registrant [X]
Filed by a Party other than the Registrant [_]
Check the appropriate box:
[_] Preliminary Proxy Statement [_] Confidential, for Use of the
Commission Only (as permitted by
Rule 14a-6(e)(2))
[X] Definitive Proxy Statement
[_] Definitive Additional Materials
[_] Soliciting Material Pursuant to Section 240.14a-11(c) or Section 240.14a-12
HEALTH CARE PROPERTY INVESTORS, INC.
- --------------------------------------------------------------------------------
(Name of Registrant as Specified In Its Charter)
- --------------------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
[X] $125 per Exchange Act Rules 0-11(c)(1)(ii), 14a-6(i)(1), 14a-6(i)(2)
or Item 22(a)(2) of Schedule 14A.
[_] $500 per each party to the controversy pursuant to Exchange Act Rule
14a-6(i)(3).
[_] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
(1) Title of each class of securities to which transaction applies:
-------------------------------------------------------------------------
(2) Aggregate number of securities to which transaction applies:
-------------------------------------------------------------------------
(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (Set forth the amount on which
the filing fee is calculated and state how it was determined):
-------------------------------------------------------------------------
(4) Proposed maximum aggregate value of transaction:
-------------------------------------------------------------------------
(5) Total fee paid:
-------------------------------------------------------------------------
[_] Fee paid previously with preliminary materials.
[_] Check box if any part of the fee is offset as provided by Exchange
Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee
was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
(1) Amount Previously Paid:
-------------------------------------------------------------------------
(2) Form, Schedule or Registration Statement No.:
-------------------------------------------------------------------------
(3) Filing Party:
-------------------------------------------------------------------------
(4) Date Filed:
-------------------------------------------------------------------------
Notes:
<PAGE>
HEALTH CARE PROPERTY INVESTORS, INC.
----------------
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD APRIL 25, 1996
The Annual Meeting of Stockholders of Health Care Property Investors, Inc.
(the "Company") will be held in the Marquis Room of the Westwood Marquis
Hotel, 930 Hilgard Avenue, Los Angeles, California 90024 on Thursday, April
25, 1996, at 9:30 a.m., Los Angeles time, for the purposes of (1) electing two
Directors, (2) ratifying the selection of Arthur Andersen LLP as independent
accountants for the fiscal year ending December 31, 1996, and (3) transacting
such other business as may properly come before the meeting.
Only Stockholders whose names appear of record on the books of the Company
at the close of business on February 23, 1996 are entitled to notice of, and
to vote at, such Annual Meeting or any adjournment or adjournments thereof.
You are cordially invited to attend the meeting in person. Whether or not
you expect to attend this meeting, please sign and date the enclosed proxy and
return it as promptly as possible in the enclosed self-addressed, postage-
prepaid envelope. If you attend the Annual Meeting and wish to vote in person,
your proxy will not be used.
By Order of the Board of Directors
/s/ Edward J. Henning
Edward J. Henning
Corporate Secretary
Los Angeles, California
March 19, 1996
<PAGE>
HEALTH CARE PROPERTY INVESTORS, INC.
----------------
PROXY STATEMENT
This proxy statement is furnished to the Stockholders of Health Care
Property Investors, Inc., a Maryland corporation (the "Company"), in
connection with the solicitation of proxies by the Board of Directors of the
Company for use at the Annual Meeting of Stockholders to be held on April 25,
1996, and at any and all adjournments thereof. The principal executive offices
of the Company are located at 10990 Wilshire Boulevard, Suite 1200, Los
Angeles, California 90024. The approximate date on which this proxy statement
and form of proxy solicited on behalf of the Board of Directors will be sent
to the Company's Stockholders is March 19, 1996.
On February 23, 1996, the record date for the determination of Stockholders
entitled to notice of, and to vote at, the Annual Meeting, the Company had
28,610,614 shares of common stock, par value $1.00 per share (the "Shares" or
the "Common Stock"), outstanding. Each such Share is entitled to one vote on
all matters properly brought before the meeting. Stockholders are not
permitted to cumulate their Shares for the purpose of electing Directors or
otherwise.
A person giving the enclosed proxy has the power to revoke it at any time
before it is exercised. The power of the proxy is suspended if the person
giving it attends the meeting and elects to vote in person.
PRINCIPAL STOCKHOLDERS
The following table sets forth information as of March 1, 1996, with respect
to each person who is known by the Company to own beneficially more than 5% of
its Shares and with respect to Shares owned beneficially by all Directors and
executive officers of the Company as a group.
<TABLE>
<CAPTION>
SHARES BENEFICIALLY OWNED
---------------------------------
NATURE OF BENEFICIAL AMOUNT AND NATURE OF PERCENT
OWNER ADDRESS OF BENEFICIAL OWNER BENEFICIAL OWNERSHIP (1) OF CLASS
-------------------- --------------------------- ----------------------- --------
<S> <C> <C> <C>
Scudder, Stevens & 345 Park Avenue 1,985,650(2) 6.9%
Clark, Inc............. New York, NY 10154
Loomis, Sayles & One Financial Center 1,888,900(3) 6.6%
Company, L.P........... Boston, MA 02111
Cohen & Steers Capital 757 Third Avenue 1,670,800(2) 5.8%
Management, Inc........ New York, NY 10017
All Directors and
executive officers as
a group (11 persons)... 738,255(4) 2.5%(4)
</TABLE>
- --------
(1) Nature of beneficial ownership is sole voting and/or investment power.
(2) Based on information as of December 31, 1995 obtained by the Company from
the beneficial owners listed.
(3) Based on information as of February 12, 1996 obtained by the Company from
the beneficial owner listed.
(4) Includes 409,140 Shares purchasable within 60 days upon exercise of
outstanding stock options.
1
<PAGE>
ELECTION OF DIRECTORS
Pursuant to the Company's Articles of Incorporation, as amended and restated
to date (the "Articles of Incorporation"), the Directors have been divided
into three classes, each being elected to hold office for a term of three
years and until their respective successors have been duly elected and
qualified. At the Annual Meeting, two Directors will be elected in one class
to hold office for a term of three years and, in each case, until their
respective successors have been duly elected and qualified. The remaining
Directors shall continue in office until their respective terms expire and
until successors have been duly elected and qualified.
The nominees for election to the two positions of Director to be voted upon
at the Annual Meeting are Kenneth B. Roath and Orville E. Melby. Unless
authority to vote for the election of Directors has been specifically
withheld, the persons named in the accompanying proxy intend to vote for the
election of Messrs. Roath and Melby to hold office as Directors for a term of
three years each and until their respective successors have been duly elected
and qualified.
If any nominee becomes unavailable for any reason (which event is not
anticipated), the Shares represented by the enclosed proxy may (unless such
proxy contains instructions to the contrary) be voted for such other person or
persons as may be determined by the holders of such proxies. In no event will
the proxy be voted for more than two nominees.
BOARD OF DIRECTORS AND OFFICERS
The executive officers of the Company, nominees for election as Directors of
the Company and the other persons whose terms as Directors continue after the
meeting, and their principal occupations for the past five years or more,
their ages, their positions and offices with the Company, information as to
their terms in office as Directors, and the number of Shares of the Company
owned beneficially by them on March 1, 1996, are as follows:
<TABLE>
<CAPTION>
SHARES BENEFICIALLY OWNED (1)
------------------------------------
NUMBER OF PERCENT
FIRST TERM NUMBER OPTION OF
NAME AGE ELECTED EXPIRES OF SHARES SHARES (2) CLASS (3)
---- --- ------- ------- ---------- ---------- -----------
<S> <C> <C> <C> <C> <C> <C>
Paul V. Colony.......... 56 1988 1998 10,200 18,000 (4)
Robert R. Fanning, Jr... 53 1985 1997 879 36,000 (4)
Devasis Ghose........... 42 -- -- 16,370 19,740 (4)
Edward J. Henning....... 42 -- -- 10,300 2,100 (4)
Stephen R. Maulbetsch... 38 -- -- 11,410 19,440 (4)
Michael D. McKee........ 50 1989 1997 2,200 18,000 (4)
Orville E. Melby........ 74 1985 1996 10,000 25,500 (4)
Harold M. Messmer, Jr... 50 1985 1997 20,100(5) 18,000 (4)
James G. Reynolds....... 44 -- -- 30,620 85,200 (4)
Peter L. Rhein.......... 54 1985 1998 32,000 18,000 (4)
Kenneth B. Roath........ 60 1986 1996 185,056 149,160 1.15%
</TABLE>
2
<PAGE>
- --------
(1) Except as otherwise noted below, all Shares are owned beneficially by the
individual listed with sole voting and/or investment power.
(2) Consists of Shares purchasable within 60 days upon exercise of outstanding
stock options.
(3) For purposes of computing the percentages, the number of Shares
outstanding includes Shares purchasable by such individual within 60 days
upon exercise of outstanding stock options.
(4) Less than 1%.
(5) Includes 7,600 Shares held as custodian for his children.
Mr. Colony is a Director and has been associated in various capacities with
the insurance firm of Alexander & Alexander, Inc. for over 30 years. He is
presently Vice Chairman of Alexander & Alexander, Inc. and Chairman of the
Board of Alexander & Alexander of California, Inc.
Mr. Fanning is a Director and has been President of Northeast Health
Systems, Inc. since July 1983 and Beverly Hospital Corporation since 1980. Mr.
Fanning has been a member of the Massachusetts Health and Educational
Facilities Authority since 1985 and Chairman of the Authority since 1993. He
currently serves as a Director of Warren Bancorp, Inc. and is a past Chairman
of the American College of Healthcare Executives.
Mr. Ghose has been Senior Vice President-Finance and Treasurer of the
Company since January 1995 and has been with the Company since 1986. Mr. Ghose
became Vice President-Finance and Treasurer in 1994, Vice President and
Treasurer in 1991 and Vice President and Controller in 1988.
Mr. Henning became Senior Vice President, General Counsel and Corporate
Secretary of the Company in January 1995 and joined the Company in May 1994 as
Vice President, Senior Legal Counsel and Corporate Secretary. Mr. Henning was
Vice President and Legal Counsel for Weyerhaeuser Mortgage Company from 1992
to 1994 and prior thereto was an attorney with the law firm of Latham &
Watkins from 1984 to 1992.
Mr. Maulbetsch has been employed by the Company since September 1985. He
became Senior Vice President-Property and Acquisition Analysis in January 1995
after serving as Vice President-Property and Acquisition Analysis since 1988.
Mr. McKee is a Director and has been Executive Vice President of The Irvine
Company since April 1994. Prior thereto, he was a partner with the law firm of
Latham & Watkins from January 1986 to April 1994. Mr. McKee is a Director of
Irvine Apartment Communities, Inc. and Realty Income Corporation.
Mr. Melby is a Director and a retired Vice Chairman of Rainier National Bank
(which was subsequently acquired by Bank of America) where he served from 1974
through 1986. Prior to his service with Rainier, Mr. Melby was Treasurer and
later Vice President of Sales and Contracts of the Boeing Company.
Mr. Messmer is a Director and has been Chairman, Chief Executive Officer and
President of Robert Half International, Inc. since July 1986. Mr. Messmer is
also a Director of Airborne Freight Corporation, First Interstate Bancorp,
Pacific Enterprises and Spieker Properties.
Mr. Reynolds became Executive Vice President of the Company in January 1995
and also serves as its Chief Financial Officer. He has been employed with the
Company since its inception in 1985 and served as Senior Vice President
beginning in 1988.
3
<PAGE>
Mr. Rhein is a Director and has been a general partner of Sarlot and Rhein,
a real estate investment and development partnership, since 1967. Mr. Rhein is
a Director of Oasis Residential, Inc.
Mr. Roath is Chairman of the Board of Directors and became President and
Chief Executive Officer of the Company in May 1988, having previously served
as President and Chief Operating Officer since the inception of the Company in
1985. Mr. Roath is the immediate past Chairman of the National Association of
Real Estate Investment Trusts and also serves as a member of its Board of
Governors and Executive Committee. He is a Director of Franchise Finance
Corporation of America. Mr. Roath also serves as a Vice Chairman for the La
Jolla Cancer Research Foundation and as a Trustee of the California Museum of
Science and Industry.
BOARD OF DIRECTORS AND COMMITTEES OF THE BOARD
The Board of Directors held four meetings during 1995. During that period,
no incumbent Director attended fewer than 75% of the total number of meetings
of the Board and of committees of the Board on which he served.
The Company currently pays each independent Director a fee of $18,000 per
year for services as a Director plus, except as provided below for the Special
Committee, $1,000 for attendance in person at each meeting of the Board of
Directors or any committee meeting on a day on which the Board of Directors
does not meet, $400 for attendance in person at any committee meeting held on
a day on which the Board of Directors also meets, and $400 for participation
in any telephonic Board of Directors meeting or committee meeting, when such
meetings last longer than a specified time period. The Board of Directors
appointed a Special Committee in October 1995. The Chairman of the Special
Committee received $1,200 for each Special Committee meeting attended in
person and $1,000 for participation in a telephonic Special Committee when
such meetings lasted longer than a specified time period and the other
Directors on the Special Committee received $1,000 for each Special Committee
attended in person and $800 for participation in a telephonic Special
Committee meeting when such meetings lasted longer than a specified time
period. In addition, the Company reimburses the Directors for travel expenses
incurred in connection with their duties as Directors of the Company.
Non-employee Directors also participate in the Directors Stock Incentive
Plan (the "Directors Plan"). Under the Directors Plan, on the last Thursday of
April of each year, all outside Directors are granted an option as of that
date to acquire 6,000 shares of the Company's Common Stock. During 1995,
outside Directors Colony, Fanning, McKee, Melby, Messmer and Rhein were each
granted options for 6,000 shares of Common Stock at an exercise price of
$30.38 per share of Common Stock. Each option granted under the Directors Plan
is a nonqualified option to purchase shares of Common Stock (an "Option").
Options expire not later than 10 years from the date of grant. An Option
becomes exercisable one year after the date of grant. The Option exercise
price is the fair market value of a share of Common Stock on the date of the
grant.
The Directors can also participate in the Retirement Plan for Outside
Directors (the "RPOD") which provides each eligible, non-employee Director
with retirement benefits upon his retirement from the Board. A Director
becomes eligible to receive benefits under the RPOD when he reaches either age
60, provided he has served as a Director for 15 full years, or age 65,
provided he has served as a Director for five full years, and ceases to serve
on the Board. If a Director terminates service on the Board after completing
at least five full years as a Director, but before meeting the age and service
requirements set forth above, the Director will become eligible to receive a
deferred retirement benefit beginning at age 65.
4
<PAGE>
The annual retirement benefits payable to an eligible Director equal (i) the
Director's annual retainer for the 12 months preceding his retirement,
resignation or death plus (ii) the fee in effect on the date of retirement,
resignation or death for attending a regularly scheduled Board meeting
multiplied by four. Benefits under the RPOD will be paid for a period, not to
exceed 15 years, equal to the period during which the Director served on the
Board, excluding service, if any, while an employee of the Company. If a
Director dies after becoming eligible to receive benefits under the RPOD, his
beneficiary will receive benefits under the RPOD as though the Director had
retired from the Board on the day preceding his death and had met the
applicable age requirements. If a Director is terminated during the term in
which a change of control (as defined in the RPOD) occurs or is not re-elected
immediately following the expiration of such term, he is entitled to the lump
sum actuarial equivalent of the benefits he would have received had he retired
immediately, without regard to whether he meets the age and service
requirements, on the date of such termination or expiration of the Director's
term.
The Company has adopted a Deferred Compensation Plan for Directors of the
Company which permits the Directors to elect to defer fees and retainers. Any
participating Director will be paid at retirement or such earlier date as he
may designate in such election. Each Director participating in the Deferred
Compensation Plan elects the amount of deferred compensation to be credited to
(i) an interest rate account wherein the deferred amount will accrue interest
at a rate equal to the prime rate of Bank of New York minus one percent and/or
(ii) a stock credit account wherein the deferred amount is treated as if it
were invested in the Common Stock of the Company with the account increasing
for dividends paid, and increasing or decreasing with changes in the price of
the Company's Common Stock.
The Board of Directors has an Audit Committee, an Investment Committee and a
Compensation Committee, and, from October 1995 to January 1996, had a Special
Committee.
The Audit Committee is comprised of Messrs. Colony, Messmer and Rhein. The
Audit Committee held two meetings during 1995. The Audit Committee is
authorized to select the independent accountants to serve the Company for the
ensuing year, subject to Stockholder approval; review with the independent
accountants the scope and results of the audit; review management's evaluation
of the Company's system of internal controls; and review non-audit
professional services provided by the independent accountants and the range of
audit and non-audit fees. To ensure independence of the audit, the Audit
Committee consults separately and jointly with the independent accountants and
management.
The Investment Committee is comprised of Messrs. Fanning, Melby, Rhein and
Roath. The Investment Committee held eight meetings during 1995. The
Investment Committee is authorized to approve all real estate acquisitions and
other investments.
The Compensation Committee is comprised of Messrs. McKee, Melby and Messmer.
The Compensation Committee held three meetings during 1995. The Compensation
Committee is responsible for the administration of the Company's employee
benefit plans. The Compensation Committee is authorized to determine the
persons eligible to participate in any of the plans, the extent of such
participation and the terms and conditions under which benefits may be vested,
received or exercised. The Compensation Committee also reviews and approves
the compensation of the Company's executive officers and determines the
general compensation policy for the Company.
The Special Committee was established in October 1995 for the limited
purpose of evaluating claims made by certain of the limited partners in a
partnership in which the Company had been general partner and a fifty percent
equity interest owner since 1985. Such claims were resolved in January 1996
and the Special Committee has been dissolved. The Special Committee was
comprised of Messrs. Colony, Fanning, Melby and Rhein. The Special Committee
held six meetings during 1995.
5
<PAGE>
EXECUTIVE COMPENSATION
SUMMARY COMPENSATION TABLE
<TABLE>
<CAPTION>
ANNUAL COMPENSATION LONG-TERM COMPENSATION
---------------------- --------------------------------------
RESTRICTED
NAME AND PRINCIPAL STOCK STOCK ALL OTHER
POSITION YEAR SALARY BONUS AWARDS(1)(2) OPTIONS COMPENSATION(3)
------------------ ---- -------- -------- ------------ ------- ---------------
<S> <C> <C> <C> <C> <C> <C>
Kenneth B. Roath 1995 $422,840 $408,000 $1,430,600(4) 100,000 $30,000
Chairman, President 1994 384,400 370,000 425,600 30,000 30,000
and Chief Executive 1993 373,000 360,000 291,300 100,000
Officer
James G. Reynolds 1995 239,200 159,000 198,600(4) 32,000 21,000
Executive Vice 1994 207,200 156,000 241,200 5,000 20,000
President and Chief 1993 196,800 122,000 113,400 40,000
Financial Officer
Edward J. Henning (5) 1995 166,800 53,000 125,100(4) 27,000 9,000
Senior Vice President, 1994 89,000 25,000 156,000 3,000 0
General Counsel and
Corporate Secretary
Devasis Ghose 1995 135,000 25,000 96,900(4) 20,000 21,000
Senior Vice President-- 1994 114,000 26,000 141,900 2,700 17,000
Finance and Treasurer 1993 104,600 20,000 24,800 8,000
Stephen R. Maulbetsch 1995 110,000 26,000 97,800(4) 20,000 13,000
Senior Vice President-- 1994 89,600 23,000 141,900 2,700 11,000
Property and
Acquisition Analysis 1993 84,600 14,000 20,400 7,500
</TABLE>
- --------
(1) Other than the May 1995 restricted stock grants discussed in footnote 4
below, restricted stock awards vest ratably over five years. The table
below shows the amounts of restricted stock held at December 31, 1995, the
value of such restricted stock (calculated by multiplying the amount of
restricted stock by the closing market price of $35.125 on the last
trading day of 1995) and total restricted stock awards granted for the
past three years. Dividends are paid on the restricted shares at the same
rate as on all other shares of Common Stock of the Company.
<TABLE>
<CAPTION>
VALUE OF RESTRICTED STOCK GRANTS WITH
RESTRICTED STOCK RESTRICTED RESPECT TO INDICATED YEAR
SHARES AT STOCK AT -----------------------------
DECEMBER 31, 1995 DECEMBER 31, 1995 1993 1994 1995
----------------- ----------------- --------- --------- ---------
<S> <C> <C> <C> <C> <C>
Kenneth B. Roath........ 74,460 $2,615,000 10,000 15,000 45,000
James G. Reynolds....... 19,020 668,000 3,900 8,500 5,800
Edward J. Henning....... 7,100 249,000 0 7,500 3,600
Devasis Ghose........... 7,380 259,000 850 5,000 2,820
Stephen R. Maulbetsch... 6,780 238,000 700 5,000 2,850
</TABLE>
(2) Long-term incentive stock award amounts have been calculated based upon
the closing market price as of the date of grant.
(3) These amounts represent the Company's contributions to the Company's
401(k) Plan (as defined below) and, for Mr. Roath only, also includes the
value of $9,000 of premiums paid in 1995 by the Company for term life
insurance of which the Company is not the beneficiary and which premiums
are taxable income to Mr. Roath. Information for years prior to 1994 is
not required to be disclosed.
6
<PAGE>
(4) In May 1995, the Compensation Committee made special grants of restricted
stock to Messrs. Roath, Reynolds, Henning, Ghose and Maulbetsch of 30,000,
800, 100, 320 and 350 shares respectively, having market value on the
grant date of $907,500, $24,200, $3,025, $9,680 and $10,590, respectively.
Discussion regarding Mr. Roath's grants appears under the caption "Chief
Executive Compensation." Mr. Roath's special restricted stock grant vests
40% after two years and 20% per year thereafter and the grants for Messrs.
Reynolds, Henning, Ghose and Maulbetsch vested November 1, 1995. The
remainder of the amounts reported reflects the January 1996 grants of
restricted stock for 1995 performance in connection with the annual year-
end review of compensation. These grants were of 15,000, 5,000, 3,500,
2,500 and 2,500 shares to Messrs. Roath, Reynolds, Henning, Ghose and
Maulbetsch, respectively, and had market values on the grant date of
$523,100, $174,400, $122,100, $87,200 and $87,200, respectively.
(5) Mr. Henning became an employee of the Company on May 23, 1994. 1994
compensation figures do not include the 7,500 stock options or the 2,000
restricted shares (having a market value of $63,500 on the grant date) he
received upon commencement of employment. The table in footnote 1 showing
Mr. Henning's 7,500 restricted stock grants for 1994 includes the 2,000
shares he received in May 1994 and the 5,500 shares he received in January
1995 for 1994 performance.
Employment Agreement. On April 28, 1988, the Company entered into an
employment agreement (the "Agreement") with Kenneth B. Roath which was amended
as of January 31, 1991. The Agreement is for a term of three years and will
automatically be extended for an additional year on the last day of January of
each year unless earlier terminated pursuant to the terms of the Agreement.
The Agreement provides for a base salary for the twelve calendar months
beginning February 1, 1991 at the annual rate of $320,000 to be adjusted
annually at the discretion of the Board of Directors, but at a minimum to
reflect increases in the Consumer Price Index. For 1996, the Compensation
Committee recommended, and Mr. Roath agreed, that there be no increase in
Mr. Roath's base salary over 1995 levels in order to maintain his total
compensation leveraged toward performance based incentives. The Agreement
provides for bonus compensation. Mr. Roath is also entitled to the payment by
the Company for the term of the Agreement of premiums for a term life
insurance policy in the amount of $2,000,000 insuring Mr. Roath's life with a
beneficiary named by Mr. Roath. If Mr. Roath's employment is terminated by a
change in control or without cause, he is entitled to receive in severance pay
either (i) his annual base salary at the time of termination plus an amount
equal to two times the average annual bonus earned by Mr. Roath in the two
years immediately preceding the date of termination, subject to a reduction by
the amount of compensation that he receives from a new employer during what
would have been the remainder of his term of employment with the Company, or
(ii) upon thirty (30) days' written notice, a lump sum equal to the present
value of the flow of cash payments that he would otherwise have been paid, but
in no event shall payment be less than 2.5 or 1.5 times base salary for the
applicable period for termination due to change in control or without cause,
respectively.
COMPENSATION PURSUANT TO PLANS
Section 401(k) Plan. In 1988, the Company adopted a tax-qualified cash or
deferred profit-sharing plan (the "401(k) Plan"). Under the 401(k) Plan, which
covers all Company employees after they have completed one year of service,
employees may elect to reduce their current compensation up to a maximum of
$9,240 for 1995 and $9,500 for 1996 and have the amount of the reduction
contributed to the 401(k) Plan. The Company also contributes to the 401(k)
Plan an amount equal to the lesser of $6,000 or 4% of such employee's
compensation if such employee's contribution is at least the lesser of 3% of
his compensation or the maximum contribution allowable by law. The employee's
right to retain the Company's contributions vests at the rate of 20% per year,
beginning after the employee has been with the Company for two years. The
401(k) Plan is intended to qualify
7
<PAGE>
under Section 401 of the Internal Revenue Code so that contributions by
employees or by the Company are not taxable to employees until withdrawn from
the 401(k) Plan, and so that contributions by the Company will be deductible
by the Company when made. For the fiscal year ended December 31, 1995 the
Company made contributions pursuant to the 401(k) Plan including Section
401(a) contributions discussed further below as follows: $85,000 on behalf of
its five most highly compensated executive officers each of whose total
remuneration exceeded $60,000 during such fiscal year; and $169,000 on behalf
of all employees as a group. At December 31, 1995, each of the 20 employees of
the Company was a participant in the 401(k) Plan.
In 1993, the Compensation Committee adopted an amendment to the Company's
401(k) Plan to provide for a Section 401(a) profit sharing contribution as
provided for and set forth in the Internal Revenue Code. Contributions under
the 401(k) Plan are subject to various limitations under the Internal Revenue
Code and maximum combined employee and employer 401(k) and 401(a)
contributions were limited to the lesser of 25% of taxable compensation or
$30,000 per person in 1995.
Supplemental Executive Retirement Plan. Effective May 1, 1988, and amended
effective January 1, 1993, the Board of Directors adopted a Supplemental
Executive Retirement Plan (the "SERP") which provides certain executives
selected by the Compensation Committee with supplemental deferred benefits in
the form of retirement payments for life. Currently, the Compensation
Committee has selected Kenneth B. Roath to be a participant.
The annual retirement benefit available to a participant under the SERP
varies according to (i) the age of the participant at retirement, with the
youngest retirement age being 55, and (ii) the number of years the participant
has served the Company, with minimum service being five years. The normal
retirement benefit payable to a participant will equal 30% of his final
average earnings plus 4% of his final average earnings multiplied by years of
service after age 60 (not to exceed five years). Final average earnings are
defined under the plan to mean the average of the three highest, not
necessarily consecutive, years' earnings. A participant's earnings include
total annual cash compensation, including base salary and annual incentive
awards, and deferred cash compensation including 401(a) contributions made by
the Company under the 401(k) Plan described above. If a participant retires
before age 65, his benefits may be subject to reduction for early retirement.
The SERP benefit is reduced by 100% of any retirement benefit received from
any other Company retirement plan available to a participant (other than
Section 401(a) and Section 401(k) contributions) and Social Security. In the
event of death of a participant after retirement, 50% of the benefit earned by
the participant will be paid to the surviving spouse for life and if survived
by dependent children, each such child will receive a benefit equal to $1,500
per month until age 18, or age 25 if a full time student. In the event of a
participant's death prior to retirement, the participant's surviving spouse
will be paid the participant's retirement benefit as if the participant had
retired the day before his or her death.
The table below indicates for a range of final average earnings, anticipated
annual benefits payable if Mr. Roath retired and chose to receive benefits at
various ages between age 60 and age 65:
ANTICIPATED ANNUAL BENEFITS
AT AGES LISTED BELOW
<TABLE>
<CAPTION>
FINAL
AVERAGE
EARNINGS 60 61 62 63 64 65
-------- -------- -------- -------- -------- -------- --------
<S> <C> <C> <C> <C> <C> <C>
$725,000 $163,000 $197,000 $234,000 $274,000 $317,000 $363,000
775,000 N/A 211,000 250,000 293,000 339,000 388,000
825,000 N/A 224,000 266,000 312,000 361,000 413,000
875,000 N/A 238,000 283,000 331,000 382,000 438,000
</TABLE>
8
<PAGE>
A life insurance policy has been purchased on the life of Mr. Roath naming
the Company as sole beneficiary to provide for a portion of the obligations
under the SERP. The policy is designed so that the Company will recover a
portion of its SERP payments plus a factor for the use of its money.
The Company believes that the SERP aids in the ability to attract, retain,
motivate and provide financial security to management employees who render
valuable services to the Company.
OPTION GRANTS WITH RESPECT TO 1995
<TABLE>
<CAPTION>
PERCENTAGE
OPTIONS OF TOTAL EXERCISE PRICE(1) EXPIRATION
NAME GRANTED OPTIONS GRANTED ($/SH) DATE VALUATION(2)
---- ------- --------------- ----------------- ---------- ------------
<S> <C> <C> <C> <C> <C>
Kenneth B. Roath........ 100,000 44.05% $34.875 1/25/06 $347,000
James G. Reynolds....... 32,000 14.10% 34.875 1/25/06 111,040
Edward J. Henning....... 27,000 11.89% 34.875 1/25/06 93,690
Devasis Ghose........... 20,000 8.81% 34.875 1/25/06 69,400
Stephen R. Maulbetsch... 20,000 8.81% 34.875 1/25/06 69,400
</TABLE>
- --------
(1) The market price on the date of the grant was the same as the exercise
price.
(2) Calculated using the Black Scholes option valuation methodology, as
recommended by Shuman Management Consulting, an executive compensation
consulting firm. In using such methodology, the following variables were
utilized: risk-free rate of return of 5.75%; .1905 five year volatility
factor; 6.3% dividend yield; 3% termination discount factor; ten-year
option term; which yields a discount Black Scholes value for such stock
options of $3.47. The actual value, if any, that an executive officer may
realize will depend on the excess of the closing market price over the
exercise price on the date the option is exercised so that there is no
assurance that the value realized by an executive officer will be at or
near the value estimated by the Black Scholes model, which is based on
assumptions as to variables such as stock price volatility, future
dividend yield, interest rates and exercise term.
AGGREGATED OPTION EXERCISES IN 1995 AND OPTION VALUES AT DECEMBER 31, 1995
<TABLE>
<CAPTION>
NUMBER OF VALUE OF UNEXERCISED
UNEXERCISED OPTIONS IN-THE-MONEY OPTIONS AT
VALUE AT DECEMBER 31, 1995 DECEMBER 31, 1995(3)
SHARES ACQUIRED AT ---------------------------- -------------------------
NAME ON EXERCISE EXERCISE(1) EXERCISABLE UNEXERCISABLE(2) EXERCISABLE UNEXERCISABLE
---- --------------- ----------- ----------- ---------------- ----------- -------------
<S> <C> <C> <C> <C> <C> <C>
Kenneth B. Roath........ 0 -- 92,680 198,960 $1,103,100 $2,019,100
James G. Reynolds....... 25,000 $522,000 64,700 69,300 827,600 711,300
Edward J. Henning....... 0 -- 1,500 9,000 7,400 112,300
Devasis Ghose........... 0 -- 14,240 17,260 183,500 181,600
Stephen R. Maulbetsch... 3,020 62,000 15,080 14,620 218,400 144,200
</TABLE>
- --------
(1) Value at exercise is the difference between the closing market price on
the date of exercise less the exercise price per Share, multiplied by the
number of Shares acquired on exercise.
9
<PAGE>
(2) Of the numbers set forth, 30,000, 5,000, 3,000, 2,700 and 2,700 of the
options held by Messrs. Roath, Reynolds, Henning, Ghose and Maulbetsch,
respectively, include dividend share rights, providing for the accrual of
dividends between the time the options were granted in January of 1995 and
their exercise date. The dividend shares are only collectible if an option
is exercised, and then only after the participant has held the underlying
shares for two years following exercise. Dividend share rights accrue on
such options at the same rate as dividends on the Common Stock.
(3) Calculated based on the closing market price on the last trading day of
1995 multiplied by the number of applicable Shares in-the-money, less the
total exercise price for such Shares.
Notwithstanding anything to the contrary set forth in any of the Company's
previous filings under the Securities Act of 1933, as amended, or the
Securities Exchange Act of 1934, as amended, that might incorporate future
filings, including this Proxy Statement, in whole or in part, the following
report and the Stock Performance Graph shall not be incorporated by reference
into any such filings.
COMPENSATION COMMITTEE REPORT TO STOCKHOLDERS
The Compensation Committee of the Board of Directors, comprised of outside,
independent members of the Board, is responsible for establishing and
governing the compensation and benefit practices of the Company. The
Compensation Committee establishes the general compensation policies of the
Company, reviews and approves compensation of the executive officers of the
Company and administers all of the Company's employee benefit plans. The
Compensation Committee reviews the overall compensation program of the Company
to assure that it (i) is reasonable and consistent with practices of
comparably sized Real Estate Investment Trusts ("REITs") and real estate
development organizations, (ii) adequately recognizes performance tied to
creating stockholder value, and (iii) achieves the Company's goals of
promoting financial and operational success by attracting, motivating and
facilitating the retention of key employees with outstanding talent and
ability. The Compensation Committee believes that the primary focus of the
Company's compensation program should be to reward performance as measured by
the creation of value for stockholders. To this end, the Compensation
Committee has committed to a highly leveraged program that emphasizes
incentives tied directly to stockholder value creation. In addition, the
compensation program is designed to promote teamwork, initiative and
resourcefulness on the part of key employees whose performance and
responsibilities directly affect Company profits. In this regard, the
compensation program is designed to provide short- and long-term incentive
compensation to achieve desired results and, above all, to reward performance.
The Compensation Committee reviews with the Board of Directors all aspects of
compensation for the Company's executive officers.
The Compensation Committee makes its compensation decisions based on an
analysis of the Company's performance and an evaluation of comparative
compensation information. To assist it in this regard, the Compensation
Committee has retained the services of Shuman Management Consulting
("Shuman"), an executive compensation consulting firm. The Compensation
Committee reviews survey and other data supplied by Shuman in the course of
its deliberations relating to compensation decisions and Shuman provides
advice to the Compensation Committee with respect to the reasonableness of the
compensation paid to its executive officers. The surveys provided by Shuman
compare the Company's performance and compensation program with the
performance and compensation programs of REITs and predominantly real estate
organizations which have characteristics in common with the Company such as
assets, market capitalization and performance ("Competitive Practices"). Some,
but not all, of the companies included in the Stock Price Performance Graph
are included in such compensation surveys.
10
<PAGE>
Among other information, the Compensation Committee took into consideration
that in 1995, the Company achieved its 11th consecutive year of record setting
results with a total return to stockholders for 1995 of 24% and an average 25%
total return to stockholders for the past five years, reported by Shuman to
approximate the 70th and 75th percentile of similar results of Competitive
Practices, respectively. The Compensation Committee also noted Shuman's report
that the Company's total return to stockholders is approximately 1.5 times
that of all equity REITs for 1995 and for the past five years. In addition,
growth in funds from operations for 1995 approximated the 55th percentile and
has approximated the 90th percentile for the average of the past five years.
COMPENSATION MIX
The Company's executive compensation is based on three components, base
salary, annual cash incentive bonuses and long term stock incentive awards,
designed in each case to accomplish the Company's compensation philosophy. The
Compensation Committee targets base salary levels within the 50th to 75th
percentile of Competitive Practices and rewards excellent performance through
incentive compensation tied to shareholder value creation, which has resulted
in total compensation falling between the 75th and 90th percentiles. The
Compensation Committee has also committed to a highly leveraged program that
results in 75% of total direct compensation comprised of incentives tied
directly to shareholder value creation.
Base Salary. Salaries for executive officers are reviewed by the
Compensation Committee on an annual basis. The Compensation Committee
generally targets base salary levels within the range of the 50th to 75th
percentile of Competitive Practices. Salaries may be increased based upon an
assessment of competitive pay levels or the individual's contribution to the
asset and financial growth of the Company. The Compensation Committee has
reviewed the base salary for each of the executive officers for 1995 and
believes that such compensation is reasonable in view of Competitive
Practices, the Company's performance and the contribution of those officers to
that performance.
Annual Cash Incentive Awards. Annual cash bonus incentive awards are
generally designed to promote stockholder interests by establishing a funds
from operations target, an objective criterion which is an industry standard
measurement of the Company's performance, and an objective business
development target (collectively, the "Performance Targets"). The Performance
Targets are established by the Compensation Committee at the beginning of each
year at a level considered to provide stockholders with an acceptable rate of
return, and to enable an acceptable rate of return to be sustained. In
addition to satisfying the Performance Targets, bonus awards are also based on
personal performance measured by the extent to which personal goals are
achieved. Personal performance goals necessarily vary between executive
officers based upon their specific roles within the Company and specific
objectives established each year for each executive officer by the Company's
Chief Executive Officer. The annual cash bonus incentive awards are more
heavily weighted towards satisfaction of the Performance Targets, consistent
with the Compensation Committee's focus on tying incentive compensation to
stockholder value creation.
A target award is established for each executive officer other than the
Chief Executive Officer based on the level of his position, the
responsibilities and duties involved therein and on Competitive Practices. The
Compensation Committee approves each executive officer's target award. The
target award is expressed as a percentage of base salary and ranged between
25% and 60% of base salaries in 1995. For the executive officers other than
the Chief Executive Officer, no actual award can exceed 150% of an executive
officer's target award. The Performance Targets were achieved in 1995 and
target awards were approved by the Compensation Committee.
11
<PAGE>
Long-Term Incentive Stock Plans. The Compensation Committee administers the
Company's benefits and stock plans, including the Company's Amended Stock
Incentive Plan (the "Plan"). Pursuant to the Plan, annual stock grants and
stock options have been awarded in order to retain and motivate executives to
improve long-term stock market performance. Stock options generally are
granted at 100% of the current fair market value of the Company's stock.
Generally, stock option grant and restricted stock awards vest over a five-
year period, and the executive must be employed by the Company at the time of
vesting in order to exercise the options. The Compensation Committee may make
grants based on a number of factors, including (i) the executive officer's
position in the Company, (ii) his performance of his responsibilities, (iii)
equity participation levels of comparable executives at competitive companies,
and (iv) individual contribution to the success of the Company's financial
performance. In addition, the size, frequency and type of long-term incentive
grants may be determined on the basis of tax consequences of the grant to the
individual and the Company, accounting impact and the number of shares
available for issuance. For 1995, each of the executive officers received
stock options which were based on his responsibilities and relative position
in the Company. The Compensation Committee did not consider the amount of
options and restricted stock currently held by the officers in determining the
size of current awards.
In addition to the annual stock option awards made under the Plan for 1995,
the Compensation Committee made a special grant in May 1995 of restricted
stock to the key employees of the Company, including the executive officers.
The special grant was made in recognition of the Company's 10 consecutive
years of superior returns to stockholders including total returns on an annual
basis in excess of 22% and consistent outstanding financial performance, and
to reward the long-term tenure of its executive officers that contributed to
that success.
CHIEF EXECUTIVE COMPENSATION
Mr. Roath's compensation in 1995 was leveraged 75% toward incentive
compensation with the 25% base salary component approximating the 60th
percentile of Competitive Practices and total direct compensation
approximating the 90th percentile of Competitive Practices, reflecting the
Compensation Committee's recognition of Mr. Roath's contributions to the
Company's superior financial performance in 1995. Mr. Roath received a base
salary of $422,840 in 1995 which represents an increase of approximately 10%
over his 1994 base salary. For 1996, the Compensation Committee recommended
that there be no increase in Mr. Roath's base salary over 1995 levels in order
to maintain his total compensation leveraged toward performance based
incentives. The Compensation Committee also awarded Mr. Roath a cash bonus
incentive award of $408,000, restricted stock grants of 45,000 shares of
Common Stock, including the special grant of 30,000 shares of Common Stock,
and 100,000 stock option grants at an exercise price of $34.875. The special
grant of Common Stock vests 40% after two years, and 20% per year thereafter.
These awards are consistent with the Company's pay-for-performance philosophy,
reflecting Mr. Roath's consistent contribution to the financial success of the
Company since its inception, his continued contribution to the expansion of
the Company's investment portfolio and the resulting superior total return to
stockholders.
The other benefits received by Mr. Roath that are reported in the Summary
Compensation Table are provided pursuant to his Employment Agreement. See
"Executive Compensation--Employment Agreement."
Based upon the foregoing, the Compensation Committee has reviewed and
approved the total compensation for 1995 of the five most highly compensated
executive officers of the Company.
12
<PAGE>
POLICY WITH RESPECT TO SECTION 162(M)
Section 162(m) of the Internal Revenue Service Code denies deduction for
certain compensation in excess of $1,000,000 paid to executive officers,
unless certain performance, disclosure, stockholder approval and other
requirements are met. The Compensation Committee will continue to review the
effects of its compensation programs with regard to Internal Revenue Code
Section 162(m). A substantial portion of the compensation program will be
exempted from the $1,000,000 deduction limitation. The Company will continue
to evaluate alternatives to ensure executive compensation is reasonable,
performance-based, and consistent with the Company's overall compensation
objectives. The Compensation Committee reserves the right to design programs
that recognize a full range of performance criteria important to the Company's
success, even where compensation payable under such programs may not be
deductible.
Compensation Committee
Michael D. McKee
Orville E. Melby Harold M. Messmer, Jr.
Chairman
13
<PAGE>
STOCK PRICE PERFORMANCE GRAPH
The graph below compares cumulative total return of the Company, the S&P 500
Index and the Equity REIT Index of the National Association of Real Estate
Investment Trusts ("NAREIT") from January 1, 1991 to December 31, 1995. Total
return assumes quarterly reinvestment of dividends before consideration of
income taxes. The Company believes that this information demonstrates that the
compensation earned by its executive officers compares very favorably to the
Company's stockholder value.
(December 31, 1990 = 100)
(1) (1)(2)
DATE YEAR END S&P 500 EQUITY REITS HCPI
---- -------- ------- ------------ ----
12/31/90 Dec - 90 100.00 100.00 100.00
03/31/91 114.56 122.74 116.93
06/30/91 114.32 123.70 122.11
09/30/91 120.48 128.76 134.19
12/31/91 Dec - 91 130.55 135.70 159.81
03/30/92 127.22 136.60 139.34
06/29/92 129.72 140.20 161.53
09/29/92 133.74 149.76 179.06
12/30/92 Dec - 92 140.56 155.49 177.89
03/30/93 146.59 189.14 224.74
06/29/93 147.34 183.71 212.85
09/29/93 151.11 200.89 230.07
12/30/93 Dec - 93 154.60 186.06 203.82
03/31/94 148.71 192.39 232.90
06/30/94 149.31 195.93 238.43
09/30/94 156.67 191.92 235.44
12/31/94 Dec - 94 156.63 191.95 241.94
03/31/95 171.87 191.63 242.08
06/30/95 188.18 202.90 265.98
09/30/95 203.14 212.46 286.30
12/31/95 Dec - 95 215.25 221.26 301.90
(1) Source: NAREIT
(2) Includes Health Care REITs
14
<PAGE>
CERTAIN TRANSACTIONS
Since 1985, the Company has been insured through Alexander & Alexander, Inc.
insurance brokers for general liability, workmen's compensation, and other
insurance. Paul V. Colony, a Director of the Company since April 1988, is Vice
Chairman of Alexander & Alexander, Inc. and Chairman of the Board of Alexander
& Alexander of California, Inc., an affiliate of Alexander & Alexander, Inc.
The terms of such insurance policies were established after evaluation of
market rates, and were no less favorable to the Company than might have been
negotiated with an unrelated party. The premiums paid to Alexander &
Alexander, Inc. for the fiscal year ending December 31, 1995 were
approximately $278,000.
Peter L. Rhein, a Director of the Company, and Mr. Roath have remaining
balances on loans made in connection with the purchase of Shares of $115,000
and $473,576, respectively. These loans are due on July 20, 1998 and November
19, 1996, respectively.
COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
The members of the Board of Directors' Compensation Committee for fiscal
1995 were Messrs. Melby, McKee and Messmer, none of whom are employed by the
Company. Mr. Messmer was a 15.2% limited partner in Health Care Investors I, a
California limited partnership ("HCI") formed in 1985 of which the Company was
a general partner and 50% equity interest owner. HCI owned 11 long term care
facilities in Missouri, Illinois and Arkansas leased to subsidiaries of
Vencor. Following the exercise of purchase options, HCI and the general
partner of the various sublessees agreed to a sale of the nine Missouri
facilities. In connection with the disposition of the Missouri properties that
occurred in January 1996, and to resolve the adverse claims recently made by
two of the unaffiliated limited partners in HCI, the Company, upon
recommendation of the Special Committee of the Board of Directors that had
been formed to evaluate the claims, agreed to purchase all of the limited
partners' interest in HCI concurrently with the sale of the nine facilities.
Mr. Messmer received $2,050,000 as his pro rata share of (i) the net proceeds
from the Missouri sale, (ii) the value of the two remaining properties and
(iii) the $1,015,000 paid in the aggregate to all of the limited partners to
resolve the claims previously made by two unaffiliated limited partners. The
two remaining facilities are now owned 100% by the Company.
COMPLIANCE WITH SECTION 16(A) OF THE SECURITIES EXCHANGE ACT OF 1934
Section 16(a) of the Securities Exchange Act of 1934, as amended (the "1934
Act"), requires the Company's directors and executive officers, and persons
who own more than 10% of a registered class of the Company's equity securities
("Insiders"), to file with the SEC initial reports of ownership and reports of
changes in ownership of equity securities of Common Stock of the Company.
Insiders are required by SEC regulations to furnish the Company with copies of
all Section 16(a) reports they file.
To the Company's knowledge, based solely on its review of the copies of such
reports furnished to the Company and written representations from certain
Insiders that no other reports were required during the year ended December
31, 1995, all Section 16(a) filing requirements applicable to Insiders were
complied with except that (i) during the years 1993, 1994 and 1995 Mr. Fanning
received an aggregate of 168 shares under a quarterly dividend reinvestment
program for which a late Form 5 (indicating three late Form 5s) was filed in
March of 1996 and (ii) reports on Form 5 reporting dividend share equivalents
credited with respect to the option grants made to Messrs. Roath, Reynolds,
Henning, Ghose and Maulbetsch in January 1995 were filed late by such officers
for the year ended 1995.
15
<PAGE>
RATIFICATION OF THE SELECTION OF INDEPENDENT PUBLIC ACCOUNTANTS
Arthur Andersen LLP audited the Company's financial statements for the year
ended December 31, 1995 and have been the Company's auditors since the
Company's organization.
The Directors have selected the firm of Arthur Andersen LLP as independent
accountants for the Company for the fiscal year ending December 31, 1996, it
being intended that such selection would be submitted for ratification by
Stockholders. The proxy holders named in the accompanying form of proxy will
vote the Shares represented by the proxy for ratification of the selection of
Arthur Andersen LLP, unless a contrary choice has been specified on the proxy.
If Stockholders do not ratify the selection of Arthur Andersen LLP, the
selection of independent accountants will be considered by the Directors,
although the Directors would not be required to select different independent
accountants for the Company. The Directors retain the power to select another
firm as independent accountants for the Company to replace the firm whose
selection was ratified by Stockholders in the event the Directors determine
that the best interest of the Company warrants a change of its independent
accountants. A representative of Arthur Andersen LLP is expected to be present
at the April 25, 1996 Annual Meeting with an opportunity to make a statement
if he desires to do so, and such representative is expected to be available to
respond to appropriate questions.
THE BOARD OF DIRECTORS RECOMMENDS THAT STOCKHOLDERS VOTE "FOR" RATIFICATION
OF THE SELECTION OF ARTHUR ANDERSEN LLP AS THE COMPANY'S INDEPENDENT
ACCOUNTANTS FOR THE SUCCEEDING YEAR.
VOTING PROCEDURES
Under the Amended Bylaws of the Company as in effect on the date hereof,
elections of Directors shall be by a plurality of the votes cast. Stockholders
together holding a majority of the stock issued and outstanding and entitled
to vote at the Annual Meeting of Stockholders, who shall be present in person
or represented by proxy at such meeting duly called, shall constitute a quorum
for the transaction of business. The Inspector of Elections will treat Shares
represented by properly signed and returned proxies that reflect abstentions
as Shares that are present and entitled to vote for purposes of determining
the presence of a quorum and for purposes of determining the outcome of any
matter submitted to the Stockholders for a vote. Except as otherwise noted
herein, abstentions do not constitute a vote "for" or "against" any matter and
thus will be disregarded in the calculation of "votes cast."
The Inspector of Elections will treat Shares referred to as "broker non-
votes" (i.e., Shares held by brokers or nominees as to which instructions have
not been received from the beneficial owner or persons entitled to vote that
the broker or nominee does not have the discretionary power to vote on a
particular matter) as Shares that are present and entitled to vote for
purposes of establishing a quorum. For purposes of determining the outcome of
any matter as to which the broker has physically indicated on the proxy that
it does not have discretionary authority to vote, those Shares will be treated
as not present and not entitled to vote with respect to that matter (even
though those Shares are considered entitled to vote for quorum purposes and
may be entitled to vote on other matters).
16
<PAGE>
DEADLINE FOR SUBMISSION OF STOCKHOLDER
PROPOSALS FOR NEXT YEAR'S ANNUAL MEETING
The proxy rules adopted by the SEC provide that certain Stockholder
proposals must be included in the proxy statement for the Company's Annual
Meeting. For a proposal to be considered for inclusion in next year's proxy
statement, it must be received by the Company no later than November 15, 1996.
OTHER MATTERS
The Board of Directors of the Company knows of no matters to be presented at
the Annual Meeting other than those described in this proxy statement. Other
business may properly come before the meeting, and in that event it is the
intention of the persons named in the accompanying proxy to vote in accordance
with their judgment on such matters.
The cost of the solicitation of proxies will be borne by the Company. In
addition to solicitation by mail, Directors and officers of the Company,
without receiving any additional compensation, may solicit proxies personally
or by telephone or telegraph. The Company will request brokerage houses,
banks, and other custodians or nominees holding stock in their names for
others to forward proxy materials to their customers or principals who are the
beneficial owners of Shares and will reimburse them for their expenses in
doing so. The Company has retained the services of Kissel-Blake Inc., for a
fee of $7,000 plus out-of-pocket expenses, to assist in the solicitation of
proxies from brokerage houses, banks, and other custodians or nominees holding
stock in their names for others.
The Company's Annual Report to Stockholders, including the Company's audited
financial statements for the year ended December 31, 1995, is being mailed
herewith to all Stockholders of record. THE COMPANY WILL PROVIDE WITHOUT
CHARGE TO ANY PERSON SOLICITED HEREBY, UPON THE WRITTEN REQUEST OF ANY SUCH
PERSON, A COPY OF THE COMPANY'S ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED
DECEMBER 31, 1995 FILED WITH THE SEC. SUCH REQUESTS SHOULD BE DIRECTED TO
JAMES G. REYNOLDS, EXECUTIVE VICE PRESIDENT OF THE COMPANY, AT 10990 WILSHIRE
BOULEVARD, SUITE 1200, LOS ANGELES, CALIFORNIA 90024.
ALL STOCKHOLDERS ARE URGED TO COMPLETE, SIGN AND RETURN THE ACCOMPANYING
PROXY CARD IN THE ENCLOSED ENVELOPE.
By Order of the Board of Directors
/s/ Edward J. Henning
Edward J. Henning
Corporate Secretary
Los Angeles, California
March 19, 1996
17
<PAGE>
HEALTH CARE PROPERTY INVESTORS, INC.
REVOCABLE PROXY
ANNUAL MEETING OF STOCKHOLDERS
APRIL 25, 1996
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
The undersigned, as a holder of Common Stock of Health Care Property
Investors, Inc. (the "Company"), hereby appoints Kenneth B. Roath and Peter L.
Rhein as Proxies, with the full power of substitution, to represent and to vote
as designated on this card all of the shares of Common Stock of the Company
which the undersigned is entitled to vote at the Annual Meeting of Stockholders
to be held on April 25, 1996 at 9:30 A.M., or any adjournment thereof.
Unless otherwise marked, this Proxy will be voted FOR the election of the
Board of Directors' nominees to the Board of Directors and FOR the ratification
of Arthur Andersen LLP as independent auditors. If any other business is
presented at the Annual Meeting of Stockholders, the Proxy will be voted in
accordance with the discretion of the Proxies named above.
The Board of Directors recommends a vote "FOR" the nominees listed below and
"FOR" the ratification of Proposal 2.
1. ELECTION OF DIRECTORS: Kenneth B. Roath and Orville E. Melby
[_] FOR both nominees listed above [_] WITHHOLD AUTHORITY to vote
(except as marked to the for both nominees listed above
contrary hereon)
(INSTRUCTIONS: To withhold authority to vote for any individual nominee, write
that nominee's name on the line provided below.)
- --------------------------------------------------------------------------------
IMPORTANT: PLEASE DATE AND SIGN THE PROXY ON REVERSE SIDE
_________________ _________________
ACCOUNT NUMBER COMMON
_________________
D.R.S.
2. Ratification of Arthur Andersen LLP as independent auditors for the year
ending December 31, 1996.
[_] FOR[_] AGAINST[_] ABSTAIN
3. In their discretion, upon any other matter that may properly come before the
Annual Meeting of Stockholders or any adjournment thereof.
[_] FOR[_] AGAINST[_] ABSTAIN
Please mark, date and sign as
your name appears above. If
acting as executor,
administrator, trustee, guardian,
etc., you should so indicate when
signing. If the signer is a
corporation, please sign the full
corporate name, by a duly
authorized officer and indicate
the title of such officer. If
shares are held jointly, each
stockholder named should sign. If
you receive more than one proxy
card, please date and sign each
card and return all proxy cards
in the enclosed envelope.
Dated , 1996
__________________________________
Signature
__________________________________
Signature
__________________________________
PLEASE DATE, SIGN AND MAIL THIS PROXY IN THE ENCLOSED ENVELOPE.
